<
>

ADHD exemptions on rise in MLB

1/10/2009 - MLB

NEW YORK -- Baseball authorized nearly 8 percent of its
players to use drugs for ADHD last season, which allowed them to
take otherwise banned stimulants.

A total of 106 exemptions for banned drugs were given to major
leaguers claiming attention deficit hyperactivity disorder from the
end of the 2007 season until the end of the 2008 season, according
to a report released Friday by the sport's independent drug-testing
administrator.

That's up from 103 therapeutic use exemptions (TUEs) for ADHD in
2007, according to figures cited by baseball officials before a
congressional committee last year.

"This is incredible. This is quite spectacular. There seems to
be an epidemic of ADD in major league baseball," said Dr. Gary
Wadler, chairman of the committee that determines the
banned-substances list for the World Anti-Doping Agency.

He recommended an independent panel be established -- WADA
recommends at least three doctors -- to review TUE requests in what
he termed "a sport that grew up on greenies."

"I've been in private practice for a lot of years. I can count
on one hand the number of individuals that have ADD," he said.
"To say that [7.86 percent] of major league baseball players have
attention deficit disorder is crying out of an explanation. It is
to me as an internist so off the map of my own experience."

Rob Manfred, baseball's executive vice president of labor
relations, said it would be a mistake to compare ADHD in baseball
with statistics for the general population.

"We are all male. We are far younger than the general
population, and we have far better access to medical care than the
general population," Manfred said.

The National Institute of Mental Health estimates 3 percent to 5
percent of children have ADHD, according to its Web site.

There were 1,348 players subject to testing last season,
according to a baseball official who spoke on condition of
anonymity because the figure was not in the report. That was down
slightly from 1,354 the previous year.

There were a total of 19 positives from 3,486 tests, according
to the report.

There were 14 positives for banned stimulants -- all first-time
offenders, who are not subject to suspension. Five players were
suspended for performance-enhancing drugs.

Pitchers J.C. Romero and Sergio Mitre were penalized this week
after testing positive for androstenedione, which came from
contaminated supplements they purchased over-the-counter. Last
season, San Francisco catcher Eliezer Alfonso, Colorado catcher
Humberto Cota and Florida pitcher Henry Owens also were penalized.

The drugs that tripped them up were Nandrolone, Stanozolol and
testosterone, although it wasn't announced which player tested
positive for what drug.

"Pretty low numbers," union head Donald Fehr said of the five
major league suspensions.

Rep. Henry Waxman, who chaired hearings into drug use in
baseball, said he remained concerned about the large number of
exemptions.

"But overall, I am pleased with the steps taken by MLB and the
players' union to strengthen their drug testing program and
eliminate the use of steroids and other performance-enhancing
drugs," he added.

Rep. John Tierney, who brought up the issue last year, was not
available for comment.

Just eight TUEs were granted for illnesses other than ADHD:
three for hypertension, three for hypogonadism, one for
post-concussion syndrome and one for metabolic myopathy. The 114
overall TUEs was up from 111 the previous year.

"All of the prescriptions for stimulants are the result of
prescriptions written by doctors, and they also have to be passed
on by Dr. Bryan Smith," Fehr said. "I don't know what more there
is to say about that."

Starting in 2008, all TUE applications had to be approved by
Smith, the program's independent administrator.

The number of new requests for TUE exemptions for ADHD drugs
declined from 72 to 56, according to the baseball official.

Baseball toughened its testing program after the 2007 season
following recommendations by former Senate majority leader George
Mitchell, who spent 1½ years investigating performance-enhancing
drugs in baseball. Smith's annual report, which was to have been
issued by Dec. 1, was one of Mitchell's recommendations.